Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11751 - 11775 of 12677 in total
HRS-1167 is under investigation in clinical trial NCT05473624 (Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors).
Investigational
Matched Description: … HRS-1167 is under investigation in clinical trial NCT05473624 (Study of HRS-1167 as Monotherapy in Patients …
Petosemtamab is under investigation in clinical trial NCT03526835 (A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors).
Investigational
Matched Description: … -158 in Patients With Advanced Solid Tumors). ... Petosemtamab is under investigation in clinical trial NCT03526835 (A Study of Bispecific Antibody MCLA …
Pegtarviliase is under investigation in clinical trial NCT05154890 (A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency).
Investigational
Matched Description: … ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency). ... Pegtarviliase is under investigation in clinical trial NCT05154890 (A Multiple Ascending Dose Study of …
Mivelsiran is under investigation in clinical trial NCT06393712 (A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy).
Investigational
Matched Description: … Mivelsiran is under investigation in clinical trial NCT06393712 (A Phase 2 Trial of ALN-APP in Patients …
Ranpirnase is a ribonuclease enzyme found in Rana pipiens oocytes. It is being studied in the treatment of cancer. It is manufactured by Alfacell Corporation. It is the first ribonuclease to enter cancer clinical trials.
Investigational
Matched Description: … Ranpirnase is a ribonuclease enzyme found in Rana pipiens oocytes. ... It is being studied in the treatment of cancer. It is manufactured by Alfacell Corporation. …
Glutamic acid is the most common excitatory neurotransmitter in the central nervous system.
Experimental
Matched Description: … Glutamic acid is the most common excitatory neurotransmitter in the central nervous system. …
Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury.
Investigational
Matched Description: … Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury. …
Relenopride has been used in trials studying the treatment of Chronic Idiopathic Constipation.
Investigational
Matched Description: … Relenopride has been used in trials studying the treatment of Chronic Idiopathic Constipation. …
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … GSI-136 has been used in trials studying the treatment of Alzheimer Disease. …
Rontalizumab has been used in trials studying the treatment of Systemic Lupus Erythematosus.
Investigational
Matched Description: … Rontalizumab has been used in trials studying the treatment of Systemic Lupus Erythematosus. …
MK-7622 has been used in trials studying the treatment of Alzheimer's Disease.
Investigational
Matched Description: … MK-7622 has been used in trials studying the treatment of Alzheimer's Disease. …
Didox has been used in trials studying the supportive care of Gastric Cancer.
Investigational
Matched Description: … Didox has been used in trials studying the supportive care of Gastric Cancer. …
Epitizide is an agent, commonly found in combination triamterene, used to produce diuresis.
Experimental
Matched Description: … Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis. …
Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial).
Investigational
Matched Description: … Amylose is under investigation in clinical trial NCT01027325 (Resistant Starch Insulin Sensitivity Trial …
ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. Preclinical trials of ADL 10-0101 have suggested that the compound may be effective for the treatment of inflammatory pain, itch and visceral pain. Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at...
Investigational
Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer).
Investigational
Matched Description: … Lurtotecan is under investigation in clinical trial NCT00022594 (Liposomal Lurtotecan in Treating Patients …
Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers).
Investigational
Matched Description: … , and Immunogenicity of Subcutaneous MCAF5352A in Healthy Volunteers). ... Afasevikumab is under investigation in clinical trial NCT01480310 (Study to Investigate the Safety, Pharmacokinetics …
Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)).
Investigational
Matched Description: … ) in Type 1 Spinal Muscular Atrophy (SMA)). ... Branaplam is under investigation in clinical trial NCT02268552 (An Open Label Study of LMI070 (Branaplam …
Geptanolimab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)).
Investigational
Matched Description: … Geptanolimab is under investigation in clinical trial NCT03502629 (Clinical Trial in Chinese Patients …
Bucelipase alfa is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency).
Investigational
Matched Description: … ) in Patients With Cystic Fibrosis and Pancreatic Insufficiency). ... Bucelipase alfa is under investigation in clinical trial NCT00743483 (Efficacy of Bucelipase Alfa (BSSL …
Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
Investigational
Matched Description: … BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer). ... Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in
Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of Diridavumab in Japanese Healthy Participants).
Investigational
Matched Description: … and Immunogenicity of Diridavumab in Japanese Healthy Participants). ... Cr6261 is under investigation in clinical trial NCT02016066 (A Study to Assess the Safety, Pharmacokinetics …
Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusion Cancers).
Investigational
Matched Description: … Selitrectinib is under investigation in clinical trial NCT03215511 (Phase 1/2 Study of LOXO-195 in Patients …
5-methyl-2'-fluoroarauracil F-18 is under investigation in clinical trial NCT02809690 (18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer).
Investigational
Matched Description: … in Diagnosing and Characterizing Prostate Cancer). ... 5-methyl-2'-fluoroarauracil F-18 is under investigation in clinical trial NCT02809690 (18F-FMAU PET/CT …
Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma).
Investigational
Matched Description: … Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With …
Displaying drugs 11751 - 11775 of 12677 in total